E-LIB Suche - Ergebnisse für: Bracarda, S.

1

154P Five-year survival and safety outcomes from the START-..:

Arcidiacono, F. ; Anselmo, P. ; Casale, M....
ESMO Open. 9 (2024) - p. 102909 , 2024

Link: https://doi.org/10.1016/..

2

126P Chemotherapy and stereotactic ablative radiotherapy in..:

Arcidiacono, F. ; Anselmo, P. ; Casale, M....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S112 , 2023

Link: https://doi.org/10.1016/..

3

An Italian multicenter retrospective real-life analysis of ..:

Internò, V. ; Massari, F. ; Rudà, R....
ESMO Open. 8 (2023) 4 - p. 101598 , 2023

Link: https://doi.org/10.1016/..

4

OC-0763 SAbR in LA-NSCLC patients unfit for concurrent ChT-..:

Arcidiacono, F. ; Anselmo, P. ; Casale, M....
Radiotherapy and Oncology. 182 (2023) - p. S629 , 2023

Link: https://doi.org/10.1016/..

5

Validation of the Meet-URO score in patients with metastati..:

Rebuzzi, S.E. ; Signori, A. ; Buti, S....
ESMO Open. 7 (2022) 6 - p. 100634 , 2022

Link: https://doi.org/10.1016/..

6

The outstanding evolution of radical prostatectomy in the l..:

Gacci, M. ; Artibani, W. ; Bassi, P....
European Urology Supplements. 18 (2019) 9 - p. e3286 , 2019

Link: https://doi.org/10.1016/..

7

The waiting list for prostate cancer treatment in italy: An..:

Gacci, M. ; Artibani, W. ; Bassi, P....
European Urology Supplements. 18 (2019) 9 - p. e3286 , 2019

Link: https://doi.org/10.1016/..

8

Efficacy of cabozantinib vs everolimus in advanced renal ce..:

Bracarda, S. ; Choueiri, T.K. ; Powles, T....
European Journal of Cancer. 72 (2017) - p. S196 , 2017

Link: https://doi.org/10.1016/..

9

1142 Efficacy of atezolizumab (MPDL3280A) in platinum-treat..:

Van Der Heijden, M. ; Retz, M. ; Perez-Gracia, J.L....
European Urology Supplements. 15 (2016) 3 - p. e1142-e1142a , 2016

Link: https://doi.org/10.1016/..

10

96 Comorbidities and concomitant medications at time of dia..:

Gacci, M. ; Artibani, W. ; Bassi, P....
European Urology Supplements. 15 (2016) 3 - p. e96-e96a , 2016

Link: https://doi.org/10.1016/..

11

OC-0146: The PROS-IT CNR study: comorbidities and medicatio..:

Magrini, S. ; Ricardi, U. ; Bertoni, F....
Radiotherapy and Oncology. 119 (2016) - p. S66-S67 , 2016

Link: https://doi.org/10.1016/..

12

17LBA Results from an open-label, randomized, controlled Ph..:

Rini, B. ; Stenzl, A. ; Zdrojowy, R....
European Journal of Cancer. 51 (2015) - p. S718 , 2015

Link: https://doi.org/10.1016/..

13

557 Early access protocol with abiraterone acetate for Euro..:

Castellano, D. ; Bracarda, S. ; Tucci, M....
European Urology Supplements. 14 (2015) 2 - p. e557-e557a , 2015

Link: https://doi.org/10.1016/..

14

Final results from the large sunitinib global expanded-acce..:

Gore, M E ; Szczylik, C ; Porta, C...
British Journal of Cancer. 113 (2015) 1 - p. 12-19 , 2015

Link: https://doi.org/10.1038/..

15

106 Cabazitaxel adverse events are manageable in senior adu..:

Heidenreich, A. ; Bracarda, S. ; Mason, M....
European Urology Supplements. 12 (2013) 1 - p. e106-e107 , 2013

Link: https://doi.org/10.1016/..